Main Directory
Articles 2591
CME 2
eCommerce 0
Medical Web Sites Directory 93
Podcasts 94
Web Design and Hosting 2




FDA Approvals: Pristiq and Abilify
Link ID 4159
Title FDA Approvals: Pristiq and Abilify
Url http://www.medscape.com/viewarticle/571724?src=rss
Description The FDA has approved desvenlafaxine extended-release tablets (Pristiq) and a supplemental indication for oral and injectable aripiprazole (Abilify). Medscape Medical News
Category Articles > Business of Medicine
Keywords
Date Mar 21, 2008
Contact Name
Email
Write a Review   Add to My Favorite   Refer it to Friend   Report Broken Link  

Average Visitor Rating: 0.00 (out of 5)
Number of ratings: 0 Votes
Visitor Rating

 Other links at Articles > Business of Medicine
1. Undetected Cases Hinder Tuberculosis Control in India
  Although India has made considerable progress in tuberculosis (TB) control, more than a third of TB cases there still go undetected, resulting in delays in disease control, according to the World Health Organization (WHO) Report on Global Tuberculosis Control 2008 released on March 19. Reuters Health Information
Category:   Articles > Business of Medicine


2. State Policies in Pain Medicine and Legal Standards for Patient Care
  State policies on pain vary from state to state; therefore, the outcome of legal action could vary between states.
Medscape Neurology & Neurosurgery
Category:   Articles > Business of Medicine


3. Political Issues Affect Cancer Care as US Election Looms
  Although the current financial crisis has overshadowed healthcare reform, cancer care remains on the radar of both presidential candidates. Medscape Medical News
Category:   Articles > Business of Medicine


4. Medicare Coverage Decisions Often Based on Trials in Irrelevant Populations
  The Centers for Medicaid and Medicare Services (CMS) often make national coverage determinations based on clinical trials among subjects whose demographics differ substantially from those of Medicare beneficiaries, according to researchers at the University of California at San Francisco School of Medicine. Reuters Health Information
Category:   Articles > Business of Medicine


5. Aetna Profit Down on Investments, but Meets Views
  Aetna Inc posted a 44 percent drop in third-quarter profit on Wednesday, hurt by investment losses stemming from the credit crisis, and the No. 3 U.S. health insurer lowered its full-year forecast slightly. Reuters Health Information
Category:   Articles > Business of Medicine




Home      New Listings      Hot Listings      Top Rated      Editor Pick      Add a Listing      Update a Listing      Get Rated      Upgrade a Listing
Valid XHTML 1.0 Transitional   Valid CSS